Financial Architects (New Jersey)’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-3,485
Closed -$7K 1652
2016
Q4
$7K Hold
3,485
﹤0.01% 1105
2016
Q3
$6K Buy
3,485
+1,985
+132% +$2.41K ﹤0.01% 1125
2016
Q2
$1K Hold
1,500
﹤0.01% 1413
2016
Q1
$1K Buy
+1,500
New +$1.51K ﹤0.01% 1148
2015
Q3
Sell
-1,500
Closed -$3K 1003
2015
Q2
$3K Buy
+1,500
New +$4.25K ﹤0.01% 1076
2015
Q1
Sell
-750
Closed -$3K 1056
2014
Q4
$3K Hold
750
﹤0.01% 917
2014
Q3
$2K Buy
+750
New +$5.01K ﹤0.01% 841

Other funds holding MBII

Financial Architects (New Jersey)'s MBII Position: Q1 2017 in Review

Financial Architects (New Jersey) sold out of Marrone Bio Innovations, Inc. (MBII) in Q1 2017, closing a stake of 3,485 shares — an estimated $7K sold.

Financial Architects (New Jersey) first reported a position in MBII in Q3 2014 and held it in 7 quarters. The position peaked at $7K in Q4 2016. 24 funds tracked by Wall St. Rank hold MBII as of Q1 2017.

  • Financial Architects (New Jersey) reported no remaining Marrone Bio Innovations, Inc. position as of Q1 2017 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 3,485 Marrone Bio Innovations, Inc. shares in Q1 2017, an estimated $7K.
  • Financial Architects (New Jersey) first reported a position in Marrone Bio Innovations, Inc. in Q3 2014 and held it in 7 quarters.
  • Financial Architects (New Jersey)'s Marrone Bio Innovations, Inc. position peaked at $7K in Q4 2016.
  • 24 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q1 2017.

Based on Financial Architects (New Jersey)'s 13F filing for Q1 2017, filed 26 Apr 2017.